The goal of this editorial is to equip readers with opioid education resources that enable you to role model what it looks like to speak out about addiction. How are we doing as a profession speaking up about addiction? Stigma is commanded by a deep irony: where peer pressure is what likely keeps us quiet, peer support is what enables us to speak up. The "#MeToo" movement is an extraordinary example of the inertia needed to break open a taboo topic. From Hollywood celebrities to US women's gymnastics stars, it was clear that as more women spoke up about sexual harassment, well, the more women spoke out. As unnatural as it felt to talk about being harassed or abused, many simply acknowledged that it was the courage of their peers that helped them find their courage. Workplace supervisors have a front row seat for watching the epidemic and our role relates to what I consider the most straightforward definition of addiction: It is when "it" (i.e., alcohol, opioids, gambling) begins to cause problems.
When something is surrounded by stigma, not talking about it comes naturally. From topics as charged as knowing someone going to prison to others as benign as dealing with a child's bedwetting, avoidance can feel like the most reliable way to cope. But when we buy into a pattern of "Yikes, let's not talk about that!," are we complicit in social oppression? Submarining a conversation is surely incompatible with elevating understanding, but most of us simply feel uncomfortable talking about things we worry will make others uncomfortable. The "#MeToo" movement is an extraordinary example of the inertia needed to break open a taboo topic. From Hollywood celebrities to US women's gymnastics stars, it was clear that as more women spoke up about sexual harassment, well, the more women spoke out. As unnatural as it felt to talk about being harassed or abused, many simply acknowledged that it was the courage of their peers that helped them find their courage.
How are we doing as a profession, and as family members and citizens, speaking up about addiction? As I was preparing to lead a conference focused on the opioid epidemic, I was weighing how much time to allow for personal reflections during our sessions. After all, if stigma-and related silence-is a barrier to action, what better place to model what open discussions could look like than at a convening of health professionals? For an incisive essay on how easy it is for "in-groups to mark out-groups as different" and how facile we are in avoiding out-groups, read Goldberg's "On Stigma and Health."
1 So, I wondered, would it be indiscreet to ask how addiction has touched the lives of our participants? I decided to put my trepidation to the test at a luncheon attended by 12 health promotion professionals, most of whom were meeting each other for the first time. I initiated a round-robin discussion by saying: "I'm hosting a Think Tank attended by employers to discuss addiction and opioids in the workplace. Do you think I should ask about how addiction affected their lives? And, only if you are comfortable with it, perhaps you can share what you would say at such a session?"
To a person they each shared personal stories, both poignant and hopeful, that made it clear that they put openness above privacy when it came to dealing with the stigma surrounding addiction. Why was I so surprised? I am the author of a book entitled, Breaking Stone Silence: Giving Voice to HIV Prevention in Africa, and have discussed AIDS with hundreds of Africans both living with and affected by the epidemic.
2 By now one would think that I would have become inured to the caprices of individual and cultural differences relating to stigma, private lives, and public education. Those who are family survivors of the opioid epidemic are often the most effective and outspoken advocates because they feel compelled to share their stories. It's a form of healing for many. Others are finally confronting the stigma and their own silence that, in retrospect, they partially blame for losing a loved one. I have been surprised at the number of employers I have asked about opioids in their workplace who have said, "we haven't yet seen it as a problem here." At the height of the Global Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) Epidemic, America's Surgeon General C. Everett Koop published an AIDS brochure that he sent to every American household. He was vilified by many for publicizing what they viewed as a disease of immorality. What he was eventually celebrated for by most was more than moral courage. As a leader and healer, he understood how keenly linked public awareness and education were to overpowering stigma. He also knew that talking about condoms would not happen between people who didn't know that deadly STDs were proliferating. The goal of this editorial is to equip you with opioid education resources that enable you as leaders and silence breakers to role model what it looks like to speak out about addiction.
Surgeon General Jerome Adams' # 1 Priority
With today's opioid epidemic claiming 4 lives an hour in the United States, I was heartened that Surgeon General Jerome Adams, America's Newest Doctor, is naming the epidemic his number one priority. For a brief primer on his approach to assessing and confronting this disease, I recommend a webcast interview with Dr Adams hosted by Dr Robert L. Blendon as part of the "Voices of Leadership" series at the Harvard T.H. Chan School of Public Health. 3 Dr Jerome, like Koop, must be conscious of the need to confront the silence, given the first step he has planned is to launch a White House website where those affected by opioids can share their stories. Noting that the epidemic will not be solved by any one profession or sector, Adams is a believer in "better health through partnerships" and challenges each of us to ask "what is the one thing you can do?"
As an employer, and as one who advocates for employer leadership in health promotion, I feel employers, particularly middle managers, have a front row seat for watching the epidemic. Clearly, because Equal Employment Opportunity Commission (EEOC) rules protect employee privacy related to health issues, our role is not steeped in the complexity of clinical assessment or diagnosis. Instead, our role relates to what I consider the most straightforward definition of addiction: It is when "it" (ie, alcohol, opioids, gambling) begins to cause problems. Although the National Safety Council recommends supervisors be trained in recognizing addiction, only 30% of companies offer such instruction. 4 Staying focused on jobrelated behavior and vigilantly raising flags on unexplained lapses in performance and productivity may well be the farthest upstream any sector can get in early detection and referral. Mood swings, falling asleep, taking more frequent breaks, or having new financial difficulties are all warning signs that should spark a conversation with an employee. When a formerly outgoing employee becomes socially withdrawn, it is not too soon to ask, "What's up?" Addicts more often get worse before they get better.
Adams also speaks of the need to "know your audience" and to look for the overlap between science and policy in order to find the sweet spot for policy influencers. An example he finds troubling is the availability of Naloxone, a rescue drug for opioid overdose. He cites a study published by Blendon, his interviewer, who found that 52% of those informed about how Naloxone was an overdose antidote still felt it should not be available without a prescription. 5 "Naloxone is like a tourniquet," says our Surgeon General. "Why have policies that discourage its use?" Adams also advocates for education and prevention. He believes more physicians are following the prescribing guidelines of the Centers for Disease Control and Prevention, though he notes that we must not rely on pain specialists-but rather need to better leverage nurses, therapists, and occupational health professionals-if we are to build the scale of screening and brief interventions needed to curb the growth of the epidemic.
The Working Well Toolkit
For employers intent on confronting the stigma of opioid addiction, there are close parallels between dealing with mental health issues and dealing with addiction at work. Fostering a psychologically healthy organizational culture is the shared solution. To this end, a collaborative effort between the National Alliance on Mental Illness-NYC Metro, Northeast Business Group on Health, Partnership for Workplace Mental Health/American Psychiatric Association Foundation, PricewaterhouseCoopers, and The Kennedy Forum, a "Working Well toolkit" was developed that discusses how stigma and the related silence about mental health issues is a key underlying impediment to business success. 6 After 4 mental health summits that brought together 40 organizations, their final report states that there are "Four Key Principles for Driving Change." Not surprisingly, this is also the basic recipe considered necessary to confront the opioid epidemic:
Principles for Driving Change 7 I was so enthralled by the depth of his reporting that I've come to liken Dreamland to Rachel Carson's Silent Spring. Just as Carson's reportage relied on true stories to transform our thinking about how we are damaging our environment, Dreamland vividly melds a series of events showing how pharmaceutical sales tactics, physician practices, and clever innovations in illegal drug distribution all converged and conspired to drive addiction. Quinones regularly posts on his "Reporter's Blog" which remains focused on stories from around the nation that illuminate and trace the pathway to addiction.
By studying aggressive pharmaceutical sales practices beginning in the 1990s and putting those practices alongside the chronology of the development and marketing of "black tar" heroin, Quinones persuasively demonstrates that wherever opioids go, addiction and heroin follows. Not coincidentally, during the same time doctors were being trained to consider pain a "fifth vital sign" that was being undertreated, these drug dealers were inventing and refining a mightily effective retail model of distribution of black tar throughout United States. In the above-referenced webinar, Surgeon General Adams references the number of poorly run pain clinics in the United States. What starts as pain management rapidly turns into a hijacking of our amygdalas' pleasure centers and altering our very brain chemistry. What follows is not a joy ride. Quinones shows how the entrepreneurship of drugmakers from a small village in Mexico was enabled by these corrupt "pill mills" where they could so conveniently wait nearby to recruit their future customers-customers whose families would soon be torn apart. Ask Benjamin Miller, one of the contributors of this comprehensive pain report, 8 about how overdosing has run amok and he is quick to point out the problem resides with all of us. "Any time I hear someone cast aspersions at doctors who are overprescribing or drug companies who are to blame I get concerned; there is plenty of blame to go around, but what good is that if we do not get to the root cause?" Every one of us experiences pain at some time in our life, Miller reminded me, and we all have the capacity to empathize, listen, and overcome stigma by breaking the silence. "These are deaths of despair" according to Miller, who is Chief Strategy Officer at Well-Being Trust, and the "Pain in the Nation" report details state-by-state statistics foretelling the inexorable links between issues like alcohol, drugs, and suicide. As a selfdescribed "fragmentation fighter," Miller and this report press for holistic solutions where mental health is not decoupled from physical health and where health systems, payers, schools, and community leaders are full partners. The resiliency strategy detailed in the report advocates for nothing less than "meaningful conversations about things that matter." 9 
Understanding the Opioid Epidemic by PBS
What is the number one reason for a doctor visit? Pain. It's a point that writers at Public Broadcasting Service (PBS) use as a simple starting point to build a case around the complex cascade of trends that have fueled the opioid epidemic. Simply called, "Understanding the Opioid Epidemic," PBS aired a powerfully rendered blend of journalistic investigation into the march of the epidemic alongside poignant stories about lives affected by addiction. 10 Where Quinones' book is a tour de force chronicling the collision of societal, research, medical practice, and criminal justice missteps, this PBS program is a crash course in the current state of affairs of opioid use, a crisis that now knows no boundaries relating to class, race, or religion. You'll learn that half of those who turn to heroin started on opioids, often prescribed for sports injuries, and that the greatest rise in heroin use in recent years is in upper income classes. To help communities organize for an epidemic so few saw coming to their part of town, PBS also developed a "community engagement toolkit." 11 More such tools are needed now that pharmaceutical manufacturers have flooded the nation with the equivalent of a 30-day supply of opioids for every American. Where overprescribing rates are presently abating, deaths from overdoses continue to rise. Perhaps this is because pharma has built up such a robust pipeline for illegal drug dealers.
Pharma has now produced a 30-day supply of opioids for every American.
The PBS series notes, according to the US Department of Health and Human Services, that opioid abuse costs the nation 75 billion dollars each year. One interviewee says, "we needed more outrage earlier on." A prime candidate for such is the Purdue Pharma company, featured prominently in both "Dreamland" and this PBS documentary. They both infer that ground zero for the epidemic is traceable to 1996 when Purdue Pharma's marketing campaign emphasized a less than 1% addiction rate for patients using opioids. The overlap between Purdue's wrongful marketing and the aforementioned advocacy for better pain management helps explain why; though self-reported experience of pain hasn't increased since 1999, pain pill prescriptions have increased 4-fold.
Purdue Pharma would eventually pay a 600 million dollar penalty, but even after these sanctions, OxyContin remained Purdue's top selling drug. Aetna now notifies a medical center if they are housing a "super prescriber" of opioids. Still, by their definition, this is merely the top 1% of prescribers. Many now argue that pain is a symptom, not a vital sign that can be objectively measured, and that The Joint Commission and CMS pain standards need to change. In particular, policies that link reimbursement to patient satisfaction with pain relief are felt to be a sure route to persistent overprescribing. 12 
Prevention as the Cure
Many consider an obvious solution to opioid abuse is to pay for comprehensive pain management, those multimodal treatments that de-emphasize medication use and emphasize alternative therapies like exercise, meditation, yoga, massage, and acupressure or acupuncture. The irksome wrinkle in this common-sense advocacy for trying something different is that such alternatives have not been clinically proven to relieve chronic pain. Early actors like employers, community leaders, and health educators will need to step into a void that health systems and insurance companies, with their evidence-bound payment models, will likely be slower to fill. Most addictions like tobacco use, eating disorders, and alcoholism grow along a continuum. Looking way upstream, Dayna Bowen Matthew, a fellow at Brookings, writes in "Unburying the Lead" that social problems like unemployment and affordable housing are the underrepresented precursors to drug abuse prevention. 13 She argues that investing in social risk reduction activities, like promoting social skills and health behavior in our youth, are as vital to slowing the epidemic as are more usual recommendations, like reforming formulary management practices.
The positive wrinkle is that this is familiar territory for readers of this journal. The same modalities needed for replacing opioids are those that health promoters have been honing for decades to prevent and treat many other cultural and lifestyle-induced maladies.
Team approaches to treating chronic pain have long been recognized as more effective than 1:1 care, though, as above, such is also more expensive. Just as addiction grows along a continuum, healing also usually occurs along a continuum. The costs of bringing psychologists, social workers, and health educators alongside other clinicians to treat addiction are multiplied by the reality that recovery is commonly fraught with lapses and relapses. This is also a well-trodden path for the prevention and health promotion profession that has needed to simultaneously educate payers about the cost-benefit of primary prevention while doing the work of secondary prevention.
As with all acts of prevention, the benefit of stopping or slowing new opioid cases will be unknowable. Still, as each of the resources shared here has highlighted, breaking the silence about addiction is needed because "pain killers kill more than pain." That much we now know for sure.
